Volastra
Operator of a drug discovery and therapeutics company intended to treat and prevent the formation of metastatic disease. The company combines artificial intelligence, bioinformatics, and proprietary i...
Valuation
$150.6M
Market implied
Share Price
N/A
Total Raised
$149.1M
Last Round
N/A